Stroke prevention in atrial fibrillation: Closing the gap

Sean D. Pokorney; Bernard J. Gersh; Azhar Ahmad; Sana M. Al-Khatib; Melanie Blank; Megan Coylewright; Peter DiBattiste; Jeff S. Healey; Olaf Hedrich; Elaine M. Hylek; Eva Kline-Rogers; Eric D. Peterson; Phil Mendys; Michael J. Mirro; Gerald Naccarelli; Parashar Patel; Christian T. Ruff; Howard Rutman; Norman Stockbridge; Robert Temple; Christopher B. Granger

doi:10.1016/j.ahj.2018.10.004

Stroke prevention in atrial fibrillation: Closing the gap

Sean D. Pokorney, Bernard J. Gersh, Azhar Ahmad, Sana M. Al-Khatib, Melanie Blank, Megan Coylewright, Peter DiBattiste, Jeff S. Healey, Olaf Hedrich, Elaine M. Hylek, Eva Kline-Rogers, Eric D. Peterson, Phil Mendys, Michael J. Mirro, Gerald Naccarelli, Parashar Patel, Christian T. Ruff, Howard Rutman, Norman Stockbridge, Robert TempleChristopher B. Granger

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	29-38
Number of pages	10
Journal	American heart journal
Volume	210
DOIs	https://doi.org/10.1016/j.ahj.2018.10.004
State	Published - Apr 2019
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ahj.2018.10.004

Cite this

Pokorney, S. D., Gersh, B. J., Ahmad, A., Al-Khatib, S. M., Blank, M., Coylewright, M., DiBattiste, P., Healey, J. S., Hedrich, O., Hylek, E. M., Kline-Rogers, E., Peterson, E. D., Mendys, P., Mirro, M. J., Naccarelli, G., Patel, P., Ruff, C. T., Rutman, H., Stockbridge, N., ... Granger, C. B. (2019). Stroke prevention in atrial fibrillation: Closing the gap. American heart journal, 210, 29-38. https://doi.org/10.1016/j.ahj.2018.10.004

Pokorney, SD, Gersh, BJ, Ahmad, A, Al-Khatib, SM, Blank, M, Coylewright, M, DiBattiste, P, Healey, JS, Hedrich, O, Hylek, EM, Kline-Rogers, E, Peterson, ED, Mendys, P, Mirro, MJ, Naccarelli, G, Patel, P, Ruff, CT, Rutman, H, Stockbridge, N, Temple, R & Granger, CB 2019, 'Stroke prevention in atrial fibrillation: Closing the gap', American heart journal, vol. 210, pp. 29-38. https://doi.org/10.1016/j.ahj.2018.10.004

@article{aaa392ecf63045ea99b1d3afaef86dd0,

title = "Stroke prevention in atrial fibrillation: Closing the gap",

author = "Pokorney, {Sean D.} and Gersh, {Bernard J.} and Azhar Ahmad and Al-Khatib, {Sana M.} and Melanie Blank and Megan Coylewright and Peter DiBattiste and Healey, {Jeff S.} and Olaf Hedrich and Hylek, {Elaine M.} and Eva Kline-Rogers and Peterson, {Eric D.} and Phil Mendys and Mirro, {Michael J.} and Gerald Naccarelli and Parashar Patel and Ruff, {Christian T.} and Howard Rutman and Norman Stockbridge and Robert Temple and Granger, {Christopher B.}",

note = "Funding Information: Ruff: Dr Ruff reports research grants from Daiichi Sankyo and MedImmune and honoraria for Consulting/Advisory Boards from Bayer, Boehringer Ingelheim, Daiichi Sankyo, Janssen, and Portola. Funding Information: Peterson: Dr Peterson receives consultant/honoraria from AstraZeneca, Bayer, Janssen, Merck & Co, and Sanofi and research grants from AstraZeneca, Bayer, Daiichi Sankyo, Genetech, Janssen, Regeneron, Sanofi, Merck & Co, and Amgen Inc. Funding Information: Healey: Dr Healey reports research grants and speaking fees from Medtronic, Abbott, Boston Scientific, Bristol-Meyers-Squibb, and Pfizer and speaking fees from Servier. Funding Information: Mirro: Dr Mirro reports grants from Medtronic, grants from Biotronik, grants from Janssen/JNJ, and personal fees from IRhythm, as well as personal fees from Zoll, outside the submitted work. Funding Information: Granger: Dr Granger reports research support from Armetheon Inc, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, FDA, GlaxoSmithKline, Janssen, Medtronic Foundation, Merck, Novartis, and Pfizer and consulting fees from Abbvie, Armetheon Inc, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Gilead Sciences, GlaxoSmithKline, Janssen, Medscape LLC, Medtronic Inc, Merck, NIH, Novartis, Pfizer, Rho Pharmaceuticals, Sirtex, and Verseon. Funding Information: This manuscript was funded internally by the Duke Clinical Research Institute (Durham, NC). Funding support for the think tank meeting was provided through registration fees from AstraZeneca, Boehringer Ingelheim, Boston Scientific, Inc, Bristol-Myers Squibb, Daiichi Sankyo, Inc, Janssen Research & Development, Pfizer, and St Jude Medical. No government funds were used for this meeting.",

year = "2019",

month = apr,

doi = "10.1016/j.ahj.2018.10.004",

language = "English (US)",

volume = "210",

pages = "29--38",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Stroke prevention in atrial fibrillation

T2 - Closing the gap

AU - Pokorney, Sean D.

AU - Gersh, Bernard J.

AU - Ahmad, Azhar

AU - Al-Khatib, Sana M.

AU - Blank, Melanie

AU - Coylewright, Megan

AU - DiBattiste, Peter

AU - Healey, Jeff S.

AU - Hedrich, Olaf

AU - Hylek, Elaine M.

AU - Kline-Rogers, Eva

AU - Peterson, Eric D.

AU - Mendys, Phil

AU - Mirro, Michael J.

AU - Naccarelli, Gerald

AU - Patel, Parashar

AU - Ruff, Christian T.

AU - Rutman, Howard

AU - Stockbridge, Norman

AU - Temple, Robert

AU - Granger, Christopher B.

N1 - Funding Information: Ruff: Dr Ruff reports research grants from Daiichi Sankyo and MedImmune and honoraria for Consulting/Advisory Boards from Bayer, Boehringer Ingelheim, Daiichi Sankyo, Janssen, and Portola. Funding Information: Peterson: Dr Peterson receives consultant/honoraria from AstraZeneca, Bayer, Janssen, Merck & Co, and Sanofi and research grants from AstraZeneca, Bayer, Daiichi Sankyo, Genetech, Janssen, Regeneron, Sanofi, Merck & Co, and Amgen Inc. Funding Information: Healey: Dr Healey reports research grants and speaking fees from Medtronic, Abbott, Boston Scientific, Bristol-Meyers-Squibb, and Pfizer and speaking fees from Servier. Funding Information: Mirro: Dr Mirro reports grants from Medtronic, grants from Biotronik, grants from Janssen/JNJ, and personal fees from IRhythm, as well as personal fees from Zoll, outside the submitted work. Funding Information: Granger: Dr Granger reports research support from Armetheon Inc, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, FDA, GlaxoSmithKline, Janssen, Medtronic Foundation, Merck, Novartis, and Pfizer and consulting fees from Abbvie, Armetheon Inc, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Gilead Sciences, GlaxoSmithKline, Janssen, Medscape LLC, Medtronic Inc, Merck, NIH, Novartis, Pfizer, Rho Pharmaceuticals, Sirtex, and Verseon. Funding Information: This manuscript was funded internally by the Duke Clinical Research Institute (Durham, NC). Funding support for the think tank meeting was provided through registration fees from AstraZeneca, Boehringer Ingelheim, Boston Scientific, Inc, Bristol-Myers Squibb, Daiichi Sankyo, Inc, Janssen Research & Development, Pfizer, and St Jude Medical. No government funds were used for this meeting.

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85060997893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060997893&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2018.10.004

DO - 10.1016/j.ahj.2018.10.004

M3 - Article

C2 - 30731371

AN - SCOPUS:85060997893

SN - 0002-8703

VL - 210

SP - 29

EP - 38

JO - American Heart Journal

JF - American Heart Journal

ER -

Stroke prevention in atrial fibrillation: Closing the gap

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this